{"id":21892,"date":"2022-10-27T10:49:33","date_gmt":"2022-10-27T17:49:33","guid":{"rendered":"https:\/\/ameripharmaspe.wpengine.com\/?p=21892"},"modified":"2026-03-24T12:39:16","modified_gmt":"2026-03-24T19:39:16","slug":"scig-vs-ivig","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/scig-vs-ivig\/","title":{"rendered":"SCIG vs. IVIG: \u00bfCu\u00e1l tratamiento es mejor para usted?"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/scig-vs-ivig\/#Overview_of_Intravenous_Immunoglobulin_IVIG_vs_Subcutaneous_Immunoglobulin_SCIG\" >Descripci\u00f3n general de la inmunoglobulina intravenosa (IVIG) frente a la inmunoglobulina subcut\u00e1nea (SCIG)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/scig-vs-ivig\/#Advantages_of_IVIG_vs_SCIG\" >Ventajas de la IgIV frente a la IgSC<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/scig-vs-ivig\/#Advantages_of_SCIG_vs_IVIG\" >Ventajas de la IgSC frente a la IgIV<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/scig-vs-ivig\/#IVIG_vs_SCIG_Making_the_Right_Choice_for_the_Patient\" >IgIV vs. IgSC: la elecci\u00f3n correcta para el paciente&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/scig-vs-ivig\/#Publicly_Available_Reports_on_Patient_Preferences\" >Informes disponibles p\u00fablicamente sobre las preferencias de los pacientes<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Overview_of_Intravenous_Immunoglobulin_IVIG_vs_Subcutaneous_Immunoglobulin_SCIG\"><\/span><span style=\"font-weight: 400;\">Descripci\u00f3n general de la inmunoglobulina intravenosa (IVIG) frente a la inmunoglobulina subcut\u00e1nea (SCIG)<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">La terapia de reemplazo de inmunoglobulina (IG) se ha convertido en la piedra angular <a href=\"https:\/\/www.cdc.gov\/primary-immunodeficiency\/about\/index.html\">inmunodeficiencia primaria<\/a> Tratamiento de enfermedades (PI) en pacientes con defectos en la producci\u00f3n de anticuerpos. Los anticuerpos desempe\u00f1an un papel vital en nuestro sistema inmunitario. Act\u00faan como sistema de defensa contra sustancias extra\u00f1as que se introducen en nuestro organismo, como virus, bacterias y otras sustancias.<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-748c68330f1fe3b140ef8f9913aea3d3\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga autorizaci\u00f3n previa para IgIV\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p><span style=\"font-weight: 400;\"><a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/what-is-scig\/\">SCIG<\/a> y <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig\/\/ivig\/\">IgIV<\/a> Se preparan a partir de la sangre donada por miles de donantes humanos, lo que produce una mezcla concentrada y diversa de anticuerpos que pueden proteger a los receptores contra muchos posibles organismos infecciosos.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">La IG puede administrarse por v\u00eda intravenosa (IV) o subcut\u00e1nea (SC). Mientras que la IgIV provoca un aumento r\u00e1pido de la IG s\u00e9rica, la IgSC no. Adem\u00e1s, presenta m\u00e1s efectos secundarios que la IgSC.<\/span><\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1280\" height=\"868\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/ivig-scig-comparison.png\" alt=\"Comparison chart of IVIG and SCIG\" class=\"wp-image-28109\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/ivig-scig-comparison.png 1280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/ivig-scig-comparison-300x203.png 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/ivig-scig-comparison-1024x694.png 1024w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/ivig-scig-comparison-768x521.png 768w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/ivig-scig-comparison-18x12.png 18w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/ivig-scig-comparison-600x407.png 600w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/ivig-scig-comparison-86x58.png 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/ivig-scig-comparison-167x113.png 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/ivig-scig-comparison-280x190.png 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/ivig-scig-comparison-370x251.png 370w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/ivig-scig-comparison-960x651.png 960w\" sizes=\"auto, (max-width: 1280px) 100vw, 1280px\" \/><\/figure>\n\n\n\n<p><span style=\"font-weight: 400;\">La IgIV se administra por v\u00eda intravenosa mediante una infusi\u00f3n que suele durar de 1 a 4 horas o incluso m\u00e1s, dependiendo de la dosis y otros factores relacionados con la salud del paciente. Tras la infusi\u00f3n de IgIV, los niveles s\u00e9ricos de Ig aumentan r\u00e1pidamente, alcanzando concentraciones s\u00e9ricas m\u00e1ximas aproximadamente 15 minutos despu\u00e9s de la infusi\u00f3n, seguidos de una disminuci\u00f3n brusca de los niveles s\u00e9ricos durante las 48 horas siguientes.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">La SCIG se administra mediante inyecci\u00f3n lenta. <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig\/\/immunoglobulins-ig\/\">inmunoglobulina<\/a> En el tejido graso que se encuentra justo debajo de la piel. La IG administrada por v\u00eda subcut\u00e1nea finalmente llega a la circulaci\u00f3n a un ritmo mucho m\u00e1s lento que la IgIV, lo que resulta en niveles s\u00e9ricos de IG m\u00e1s estables, evitando los niveles m\u00e1ximos de IG que suelen acompa\u00f1ar a las infusiones de IgIV.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">No hay evidencia de que un m\u00e9todo de administraci\u00f3n sea m\u00e1s eficaz que el otro. Entonces, \u00bfpor qu\u00e9 elegir uno sobre el otro? Para responder a esta pregunta, es necesario analizar las ventajas que ofrecen la IgIV y la IgSC en comparaci\u00f3n.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Advantages_of_IVIG_vs_SCIG\"><\/span><span style=\"font-weight: 400;\">Ventajas de la IgIV frente a la IgSC<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\"><a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/what-to-expect-during-your-ivig-infusion-treatment\/\">IgIV<\/a> Por lo general, s\u00f3lo es necesario infundirlo una vez cada 3 o 4 semanas, a diferencia de las infusiones semanales de SCIG.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Puede alcanzar niveles plasm\u00e1ticos r\u00e1pidos (el medicamento exhibe su efecto m\u00e1s r\u00e1pidamente).<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Se puede utilizar en pacientes con trastornos hemorr\u00e1gicos.&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Es m\u00e1s adecuado para dosis m\u00e1s altas ya que permite infundir vol\u00famenes mayores (por ejemplo, dosis de 2 g\/kg).<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">No se necesita ninguna experiencia por parte del paciente, ya que la infusi\u00f3n se realiza en el consultorio del m\u00e9dico, en un centro de infusi\u00f3n o, si se aprueba, en el hogar del paciente en presencia de una enfermera de infusi\u00f3n que se encarga de la administraci\u00f3n del medicamento.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Generalmente implica menos pinchazos de aguja ya que solo necesita un acceso intravenoso y este proceso solo se repite una vez cada 3 o 4 semanas.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Generalmente tiene menos reacciones locales, como dolor, enrojecimiento e hinchaz\u00f3n, que con SCIG.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Es m\u00e1s adecuado para pacientes que tienen m\u00e1s dificultades para manipular agujas o para algunos padres que se sienten menos c\u00f3modos infundiendo a sus hijos peque\u00f1os con frecuencia.<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">&nbsp;<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-ebe0d49d7e45e32f021b5ce7bbb26d4f\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia para el copago de IgIV\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tHabla con un especialista\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Consulte a un especialista en IgIV<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Advantages_of_SCIG_vs_IVIG\"><\/span><span style=\"font-weight: 400;\">Ventajas de la IgSC frente a la IgIV<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-21898 size-full\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/nurse-with-patient.jpg\" alt=\"Nurse discussing IVIG and SCIG with patient\" width=\"420\" height=\"280\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/nurse-with-patient.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/nurse-with-patient-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/nurse-with-patient-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/nurse-with-patient-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/nurse-with-patient-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/nurse-with-patient-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/nurse-with-patient-370x247.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/>\n\n\n\n<li><span style=\"font-weight: 400;\">Tiene menos efectos adversos sist\u00e9micos (mejor tolerabilidad que la IgIV).<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Proporciona niveles de IG m\u00e1s uniformes en comparaci\u00f3n con la IgIV (falta de efecto pico y valle como en la IgIV).<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">No requiere entornos de infusi\u00f3n en el hospital (el paciente puede autoinfundirse en casa sin necesidad de acceso venoso).<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Ofrece mayor flexibilidad en cuanto al horario del paciente.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Generalmente es apropiado para pacientes con IP ya que generalmente requieren dosis m\u00e1s bajas de IG.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Es m\u00e1s adecuado para pacientes con acceso venoso deficiente (pacientes con punci\u00f3n dura).<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">La IGSC generalmente presenta menos reacciones adversas sist\u00e9micas, como dolor de cabeza, n\u00e1useas, v\u00f3mitos, fiebre y escalofr\u00edos, que pueden ser muy molestas aunque no pongan en peligro la vida. Estudios han demostrado que la tasa de reacciones adversas sist\u00e9micas leves en pacientes que reciben IGSC es de aproximadamente un tercio a la mitad de la tasa con IgIV. Pretratamiento antes <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig\/\/immune-globulin-injection\/\">Infusi\u00f3n de IgIV<\/a> Con antihistam\u00ednicos, acetaminofeno y, en algunos casos, esteroides sist\u00e9micos se utilizan ampliamente, pero rara vez son necesarios con infusiones de SCIG.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">La SCIG tambi\u00e9n suele ser bien tolerada por la mayor\u00eda de los pacientes que previamente hab\u00edan tenido reacciones sist\u00e9micas graves a la IVIG, y esto probablemente est\u00e9 relacionado con la velocidad m\u00e1s lenta a la que la SCIG se absorbe en la circulaci\u00f3n, lo que evita los picos altos en la IG s\u00e9rica que ocurren con las infusiones de IVIG.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">La administraci\u00f3n semanal de SCIG proporciona niveles s\u00e9ricos de IG m\u00e1s uniformes y evita los niveles valle bajos que suelen presentarse cerca del final del esquema de infusi\u00f3n de 3 o 4 semanas de IgIV, un per\u00edodo en el que algunos pacientes pueden volverse m\u00e1s susceptibles a las infecciones. Por la misma raz\u00f3n, los pacientes que reciben SCIG semanalmente tienen menos probabilidades de presentar fatiga, dolores musculares y articulares durante esos mismos per\u00edodos valle (per\u00edodos de desaparici\u00f3n del efecto).<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">La SCIG proporciona a los pacientes una sensaci\u00f3n de autonom\u00eda y les permite estar libres de viajes repetitivos a hospitales, centros de infusi\u00f3n u otras instalaciones m\u00e9dicas y, de esa manera, reduce su exposici\u00f3n a <a href=\"https:\/\/www.osmosis.org\/answers\/nosocomial-infection\">infecciones nosocomiales<\/a>Las infusiones pueden programarse despu\u00e9s de la escuela o el trabajo, o por las tardes. Estudios han demostrado que la terapia con IgSC ha resultado en menos d\u00edas de ausencia al trabajo y a la escuela que la terapia con IgIV en pacientes con IP.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">La SCIG no requiere acceso intravenoso, lo que puede ser un desaf\u00edo para los pacientes con IgIV que tienen dificultades para acceder a sus venas, y aunque pueden obtener puertos intravenosos o <a href=\"https:\/\/www.chop.edu\/treatments\/peripherally-inserted-central-catheter-picc\">L\u00edneas PICC<\/a> insertados para facilitar sus infusiones, esto los pone en mayor riesgo de infecci\u00f3n.<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-686197de78cdaf55fe16b200717d2e05\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga su dosis de IgIV\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tInfusi\u00f3n en casa\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"IVIG_vs_SCIG_Making_the_Right_Choice_for_the_Patient\"><\/span><span style=\"font-weight: 400;\">IgIV vs. IgSC: la elecci\u00f3n correcta para el paciente&nbsp;<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Se ha demostrado que las v\u00edas intravenosa y subcut\u00e1nea tienen una eficacia similar en el tratamiento de pacientes con inmunodeficiencia primaria. La v\u00eda de administraci\u00f3n de la terapia con inmunoglobulinas debe basarse en las caracter\u00edsticas del paciente, as\u00ed como en su estado de salud. Siempre es recomendable consultar con su m\u00e9dico sobre las diferentes v\u00edas de administraci\u00f3n y preguntarle si m\u00e1s de una opci\u00f3n es adecuada para usted.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Los productos de IG disponibles suelen ser espec\u00edficos para cada v\u00eda. Algunos est\u00e1n aprobados solo para administraci\u00f3n intravenosa (IV) y otros solo para administraci\u00f3n subcut\u00e1nea (SSC). Algunos productos han sido aprobados tanto para administraci\u00f3n intravenosa como subcut\u00e1nea.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Los pacientes tratados con IgSC tienen la comodidad de la administraci\u00f3n de Ig en casa, donde pueden elegir el momento y el lugar de administraci\u00f3n. En comparaci\u00f3n, la administraci\u00f3n de IgIV en un centro de salud permite un contacto frecuente con profesionales sanitarios durante el proceso, lo que se traduce en un mejor seguimiento cl\u00ednico y mejores resultados. Es importante que visite a su m\u00e9dico con la frecuencia adecuada para que pueda controlar continuamente sus an\u00e1lisis de laboratorio, hacer un seguimiento de su tratamiento y modificarlo si fuera necesario.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Es bueno saber que, incluso con IgIV, existen diferentes opciones para administrarse las infusiones, lo que puede ofrecerle mayor flexibilidad. Estas opciones son:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Pacientes hospitalizados\/ambulatorios (IVIG)<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Consultorio m\u00e9dico (IVIG)<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Centro de infusi\u00f3n ambulatoria (IVIG)<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Infusi\u00f3n domiciliaria (IVIG\/SCIG)<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">Cada uno de los lugares de administraci\u00f3n mencionados anteriormente requerir\u00e1 un m\u00e9dico o una enfermera en el lugar.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Ya sea que un paciente reciba su infusi\u00f3n de inmunoglobulina por v\u00eda intravenosa o subcut\u00e1nea, ambas terapias pueden ser muy eficaces, y el \u00e9xito del tratamiento depender\u00e1 de la colaboraci\u00f3n entre el paciente y su m\u00e9dico. Tanto la v\u00eda intravenosa como la subcut\u00e1nea est\u00e1n indicadas y son cl\u00ednicamente apropiadas para su uso en pacientes con inmunodeficiencia primaria (IP). Los pacientes deben consultar ambas opciones de tratamiento con sus m\u00e9dicos y comprender los riesgos y beneficios de cada una. Esto ser\u00e1 muy \u00fatil para decidir el r\u00e9gimen m\u00e1s adecuado para el paciente.<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-619b237c00ed20985b1319ae457b8820\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\t\u00bfPuede ayudar la IgIV?\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tInformaci\u00f3n gratuita sobre el tratamiento con IgIV\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Programar una consulta<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Publicly_Available_Reports_on_Patient_Preferences\"><\/span><span style=\"font-weight: 400;\">Informes disponibles p\u00fablicamente sobre las preferencias de los pacientes<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">En varios estudios, se pregunt\u00f3 a los pacientes que cambiaron de IgIV a IgSC qu\u00e9 m\u00e9todo prefer\u00edan.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">En un estudio realizado en EE. UU. y Canad\u00e1 en 2006, el 811% de los pacientes prefiri\u00f3 la SCIG frente a la IVIG, mientras que el 191% prefiri\u00f3 la IVIG. Un estudio de 2008 revel\u00f3 que el 100% de los pacientes suecos prefiri\u00f3 la SCIG. En un estudio reciente con 82 pacientes europeos, el 921% prefiri\u00f3 la SCIG y el 81% la IVIG. Por lo tanto, parece que la mayor\u00eda de los pacientes que prueban la SCIG la prefieren a la IVIG.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Pacientes con trastornos autoinmunes o neurop\u00e1ticos distintos de IP (p. ej., <a href=\"https:\/\/ameripharmaspecialty.com\/es\/myasthenia-gravis\/myasthenia-gravis\/\">miastenia gravis<\/a>, <a href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/what-is-multifocal-motor-neuropathy-mmn\/\">MMN<\/a>, <a href=\"https:\/\/ameripharmaspecialty.com\/es\/cidp\/what-is-cidp\/\">PDIC<\/a>, <a href=\"https:\/\/www.hopkinsmedicine.org\/health\/conditions-and-diseases\/dermatomyositis\">dermatomiositis<\/a>) que reciben terapia de dosis alta deben saber que la IGSC parece ser eficaz para estas afecciones. Sin embargo, a\u00fan no se ha investigado si la IGSC es tan eficaz como la IgIV.<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>La terapia de reemplazo con inmunoglobulina (IG) se ha convertido en la piedra angular del tratamiento de la inmunodeficiencia primaria (IP) en pacientes con deficiencias en la producci\u00f3n de anticuerpos. Los anticuerpos desempe\u00f1an un papel vital en nuestro sistema inmunitario.<\/p>","protected":false},"author":19,"featured_media":21897,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[7],"tags":[24],"class_list":["post-21892","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ivig","tag-rafik-boctor"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SCIG vs. IVIG: Which Treatment is Best? | AmeriPharma<\/title>\n<meta name=\"description\" content=\"Compare the differences between SCIG and IVIG. Learn about patient preferences, benefits, and which immunoglobulin therapy is right for you.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/scig-vs-ivig\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SCIG vs. IVIG: Which Treatment is Best? | AmeriPharma\" \/>\n<meta property=\"og:description\" content=\"Compare the differences between SCIG and IVIG. Learn about patient preferences, benefits, and which immunoglobulin therapy is right for you.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/scig-vs-ivig\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-27T17:49:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-24T19:39:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Rafik Boctor, RPh\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Rafik Boctor, RPh\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/scig-vs-ivig\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/scig-vs-ivig\\\/\"},\"author\":{\"name\":\"Rafik Boctor, RPh\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#\\\/schema\\\/person\\\/c21bfa71455c03b1365598550b1e09a0\"},\"headline\":\"SCIG vs. IVIG: Which Treatment Is Best for You?\",\"datePublished\":\"2022-10-27T17:49:33+00:00\",\"dateModified\":\"2026-03-24T19:39:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/scig-vs-ivig\\\/\"},\"wordCount\":1348,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/scig-vs-ivig\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/SCIG-vs-IVIG.jpg\",\"keywords\":[\"Rafik Boctor\"],\"articleSection\":[\"IVIG\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/scig-vs-ivig\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/scig-vs-ivig\\\/\",\"name\":\"SCIG vs. IVIG: Which Treatment is Best? | AmeriPharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/scig-vs-ivig\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/scig-vs-ivig\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/SCIG-vs-IVIG.jpg\",\"datePublished\":\"2022-10-27T17:49:33+00:00\",\"dateModified\":\"2026-03-24T19:39:16+00:00\",\"description\":\"Compare the differences between SCIG and IVIG. Learn about patient preferences, benefits, and which immunoglobulin therapy is right for you.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/scig-vs-ivig\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/scig-vs-ivig\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/scig-vs-ivig\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/SCIG-vs-IVIG.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/SCIG-vs-IVIG.jpg\",\"width\":1280,\"height\":853,\"caption\":\"SCIG vs. IVIG\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/scig-vs-ivig\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SCIG vs. IVIG: Which Treatment Is Best for You?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#\\\/schema\\\/person\\\/c21bfa71455c03b1365598550b1e09a0\",\"name\":\"Rafik Boctor, RPh\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1e32400f0b4ec39922e1405c206687bef22e2479e692243c9fd1e07606bab1dc?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1e32400f0b4ec39922e1405c206687bef22e2479e692243c9fd1e07606bab1dc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1e32400f0b4ec39922e1405c206687bef22e2479e692243c9fd1e07606bab1dc?s=96&d=mm&r=g\",\"caption\":\"Rafik Boctor, RPh\"},\"description\":\"Rafik Boctor, RPh was born and raised in Cairo, Egypt. He received his degree from the Faculty of Pharmacy, Helwan University in 2011. The most rewarding part of his job is making positive changes in patients' health and well-being on a daily basis. His areas of expertise include immunoglobulins, chemotherapy and biologics. In his free time, he enjoys playing guitar, singing, and Latin dancing.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/rafik\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SCIG vs. IVIG: \u00bfCu\u00e1l es el mejor tratamiento? | AmeriPharma","description":"Compara las diferencias entre la inmunoglobulina subcut\u00e1nea (SCIG) y la inmunoglobulina intravenosa (IVIG). Inf\u00f3rmate sobre las preferencias de los pacientes, los beneficios y qu\u00e9 terapia con inmunoglobulinas es la m\u00e1s adecuada para ti.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/scig-vs-ivig\/","og_locale":"es_MX","og_type":"article","og_title":"SCIG vs. IVIG: Which Treatment is Best? | AmeriPharma","og_description":"Compare the differences between SCIG and IVIG. Learn about patient preferences, benefits, and which immunoglobulin therapy is right for you.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/scig-vs-ivig\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2022-10-27T17:49:33+00:00","article_modified_time":"2026-03-24T19:39:16+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG.jpg","type":"image\/jpeg"}],"author":"Rafik Boctor, RPh","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Rafik Boctor, RPh","Est. reading time":"7 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/scig-vs-ivig\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/scig-vs-ivig\/"},"author":{"name":"Rafik Boctor, RPh","@id":"https:\/\/ameripharmaspecialty.com\/vi\/#\/schema\/person\/c21bfa71455c03b1365598550b1e09a0"},"headline":"SCIG vs. IVIG: Which Treatment Is Best for You?","datePublished":"2022-10-27T17:49:33+00:00","dateModified":"2026-03-24T19:39:16+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/scig-vs-ivig\/"},"wordCount":1348,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/scig-vs-ivig\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG.jpg","keywords":["Rafik Boctor"],"articleSection":["IVIG"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/scig-vs-ivig\/","url":"https:\/\/ameripharmaspecialty.com\/ivig\/scig-vs-ivig\/","name":"SCIG vs. IVIG: \u00bfCu\u00e1l es el mejor tratamiento? | AmeriPharma","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/scig-vs-ivig\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/scig-vs-ivig\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG.jpg","datePublished":"2022-10-27T17:49:33+00:00","dateModified":"2026-03-24T19:39:16+00:00","description":"Compara las diferencias entre la inmunoglobulina subcut\u00e1nea (SCIG) y la inmunoglobulina intravenosa (IVIG). Inf\u00f3rmate sobre las preferencias de los pacientes, los beneficios y qu\u00e9 terapia con inmunoglobulinas es la m\u00e1s adecuada para ti.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/scig-vs-ivig\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/ivig\/scig-vs-ivig\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/scig-vs-ivig\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG.jpg","width":1280,"height":853,"caption":"SCIG vs. IVIG"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/scig-vs-ivig\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/es\/"},{"@type":"ListItem","position":2,"name":"SCIG vs. IVIG: Which Treatment Is Best for You?"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/vi\/#website","url":"https:\/\/ameripharmaspecialty.com\/vi\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/vi\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/vi\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/vi\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/vi\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/vi\/#\/schema\/person\/c21bfa71455c03b1365598550b1e09a0","name":"Rafik Boctor, RPh","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/1e32400f0b4ec39922e1405c206687bef22e2479e692243c9fd1e07606bab1dc?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1e32400f0b4ec39922e1405c206687bef22e2479e692243c9fd1e07606bab1dc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1e32400f0b4ec39922e1405c206687bef22e2479e692243c9fd1e07606bab1dc?s=96&d=mm&r=g","caption":"Rafik Boctor, RPh"},"description":"Rafik Boctor, RPh, naci\u00f3 y creci\u00f3 en El Cairo, Egipto. Se gradu\u00f3 de la Facultad de Farmacia de la Universidad de Helwan en 2011. Lo m\u00e1s gratificante de su trabajo es generar cambios positivos en la salud y el bienestar de los pacientes a diario. Sus \u00e1reas de especializaci\u00f3n incluyen inmunoglobulinas, quimioterapia y f\u00e1rmacos biol\u00f3gicos. En su tiempo libre, disfruta tocando la guitarra, cantando y bailando latino.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/rafik\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Rafik Boctor, RPh","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/rafik\/"},"uagb_comment_info":0,"uagb_excerpt":"Immunoglobulin (IG) replacement therapy has become the cornerstone of primary immunodeficiency (PI) disease treatment in patients who have defects in their body\u2019s antibody production. Antibodies play a vital role in our immune system.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/10\/SCIG-vs-IVIG.jpg",1280,853,false]},"rttpg_author":{"display_name":"Rafik Boctor, RPh","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/rafik\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/ivig\/\" rel=\"category tag\">IVIG<\/a>","rttpg_excerpt":"Immunoglobulin (IG) replacement therapy has become the cornerstone of primary immunodeficiency (PI) disease treatment in patients who have defects in their body\u2019s antibody production. Antibodies play a vital role in our immune system.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/21892","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=21892"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/21892\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/21897"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=21892"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=21892"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=21892"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}